48 results
10-K/A
2023 FY
QLIS
Qualis Innovations, Inc.
17 Jul 24
Annual report (amended)
8:52pm
Stock | Option | All Other | ||||||||||||||||||||||||||
Fiscal | Salary | Bonus | Awards | Awards | Compensation | Total | ||||||||||||||||||||||
Name and Principal Position | Year | (1) | (2) | (3) | (4) | (5) | ($) | |||||||||||||||||||||
Mr. Patrick Adams.(10) | 2023 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
Acting CEO and Chairman of the Board | 2022 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
2021 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||||||||
Dr. Joseph V. Pergolizzi, Jr.(8) | 2023 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
Acting CEO and Chairman of the Board | 2022 | $ | - | $ | - | $ | - | $ | 290,276 | $ | - | $ | 290,276 | |||||||||||||||
2021 | $ | - | $ | - | $ | - | $ | 109,512 | $ | - | $ | 109,512 | ||||||||||||||||
John Ballard(9) | 2023 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
CFO & Director | 2022 | $ | - | $ | - | $ | - | $ | - | $ | 120,000 | $ | 120,000 | |||||||||||||||
2021 | $ | - | $ | - | $ | 130,000 | $ | - | $ | 115,000 | $ | 245,000 | ||||||||||||||||
Demir Bingol(6) | 2023 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
President | 2022 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
2021 | $ | 210,562 | $ | - | $ | - | $ | 166,141 | $ | - | $ | 376,703 | ||||||||||||||||
Robert Bilkovski, MD | 2023 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
Chief Scientific Officer | 2022 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
2021 | $ | - | $ | - | $ | - | $ | 9,161 | $ | - | $ | 9,161 | ||||||||||||||||
Austin Adams(7) | 2023 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | |||||||||||||||
2022 | $ | - | $ | - | $ | - | $ | - | $ | - | $ | - | ||||||||||||||||
20211 | $ | - | $ | - | $ | 50,000 | $ | - | $ | - | $ | 50,000 |
10-K/A
2023 FY
QLIS
Qualis Innovations, Inc.
17 Jul 24
Annual report (amended)
8:52pm
Name of Beneficial Owner | Title of Class | Amount and Nature of Beneficial Ownership | Percent of Class | |||||||
Hill Blalock Jr. | Common Stock | 7,221,045 | 35.3 | % | ||||||
Jim Holt (1) | Common Stock | 1,913,955 | 9.4 | % | ||||||
Sharon Adams (2) | Common Stock | 1,132,689 | 5.5 | % | ||||||
Austin Adams (3) | Common Stock | 600,000 | 2.9 | % | ||||||
John Ballard (4) | Common Stock | 424,500 | 2.1 | % | ||||||
Dr. Joseph Pergolizzi (5) | Common Stock | 650,000 | 3.2 | % | ||||||
Madding King (6) | Common Stock | 35,000 | - | % | ||||||
All Officers and Directors as a Group | Common Stock | 9,732,689 | 47.5 | % |
10-K/A
2023 FY
QLIS
Qualis Innovations, Inc.
17 Jul 24
Annual report (amended)
8:52pm
SUMMARY OF WARRANTS OUTSTANDING
Warrants | Weighted Average Exercise Price | Weighted Average Contract Life (in Years) | Aggregate Intrinsic Value * | |||||||||||||
Outstanding at January 1, 2022 | 1,098,830 | $ | 0.50 | 8.4 | $ | 769,181 | ||||||||||
Granted | 790,000 | 0.82 | 6.7 | - | ||||||||||||
Exercised | - | - | - | - | ||||||||||||
Expired/Forfeited | (398,830) | 0.50 | - | (538,421) | ||||||||||||
Outstanding at December 31, 2022 | 1,490,000 | $ | 0.50 | 8.4 | $ | - | ||||||||||
Granted | 100,000 | 0.05 | 3.0 | 52,000 | ||||||||||||
Exercised | - | - | - | - | ||||||||||||
Expired/Forfeited | - | - | - | - | ||||||||||||
Outstanding at December 31, 2023 | 1,590,000 | $ | 0.77 | 5.5 | $ | 101,000 | ||||||||||
Exercisable at December 31, 2023 | 1,590,000 | $ | 0.77 | 5.5 | $ | 101,000 | ||||||||||
Expected to be vested | 1,590,000 | $ | 0.77 | 5.5 | $ | 101,000 |
10-K/A
2023 FY
QLIS
Qualis Innovations, Inc.
17 Jul 24
Annual report (amended)
8:52pm
SCHEDULE OF DEFERRED TAX ASSETS
2023 | 2022 | |||||||
December 31, | ||||||||
2023 | 2022 | |||||||
Deferred tax assets: | ||||||||
Net operating loss carry forwards | $ | 617,573 | $ | 470,354 | ||||
Depreciation and amortization | 253,712 | 249,495 | ||||||
Impairment of Intangible asset | 63,964 | 35,316 | ||||||
Stock based compensation | 157,163 | 138,748 | ||||||
Valuation allowance | (1,092,412) | (893,912) | ||||||
Deferred tax assets, net | $ | - | $ | - |
10-K/A
2023 FY
QLIS
Qualis Innovations, Inc.
17 Jul 24
Annual report (amended)
8:52pm
2023 | 2022 | |||||||
For the Years Ended December 31, | ||||||||
2023 | 2022 | |||||||
Net loss attributable to the common stockholders | $ | (805,021) | $ | (920,515) | ||||
Basic weighted average outstanding shares of common stock | 8,475,950 | 8,333,660 | ||||||
Dilutive effect of options and warrants | - | - | ||||||
Diluted weighted average common stock and common stock equivalents | 8,475,950 | 8,333,660 | ||||||
Loss per share: | ||||||||
Basic and diluted | $ | (0.09) | $ | (0.11) |
10-K/A
e07kcj4eu6iyct
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
h8k315s5sy 2b
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
myi9u 8mui0mt
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
lkudorh9xeblwkez
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
7kpdmze9u pd
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
36ytgfygcjbdn115j3p
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
g5pstq179ldfq6p2rqh
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
qfbgcyncruu biac
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
q0crrnya12nyfb2
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
cnprc2jxv348f6h5
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
27tjzzfav2q3nwlthfp
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
pr9v7l g1uj
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
lz0 cqrosomel8itlgh4
17 Jul 24
Annual report (amended)
8:52pm
10-K/A
xk75ts9 ovelsxe49i
17 Jul 24
Annual report (amended)
8:52pm